| Ab subclasses |
Ab concentration (µg/ml) |
Crude rate ratio (95%CI) |
Adjusted for confounders |
LR test |
| AMA1 IgG1 |
0-368 |
1 |
1 |
X2=6.91 (2), P=0.0316 N=299 |
| 369-905 |
0.78 (0.48-1.26) |
0.79 (0.45-1.37) |
| >905 |
0.48 (0.28-0.85) |
0.39 (0.19-0.81) |
| AMA1 IgG3 |
0-11 |
1 |
1 |
X2=0.77 (2), P=0.6792 N=299 |
| 12-65 |
0.59 (0.35-0.97) |
1.15 (0.64-2.07) |
| >65 |
0.46 (0.27-0.79) |
0.85 (0.43-1.71) |
| MSP119 IgG1 |
0-28 |
1 |
1 |
X2=2.75 (2), P=0.2534 N=320 |
| 29-173 |
0.66 (0.42-1.04) |
0.97 (0.58-1.65) |
| >173 |
0.25 (0.13-0.47) |
0.57 (0.27-1.20) |
| MSP119 IgG3 |
0-6 |
1 |
1 |
X2=3.43 (2), P=0.1799 N=320 |
| 7-27 |
0.43 (0.26-0.71) |
0.59 (0.34-1.05) |
| >27 |
0.35 (0.20-0.60) |
0.73 (0.37-1.41) |
| CSP IgG1 |
<2 |
1 |
1 |
X2=9.2 (2), P=0.0101 N=401 |
| 2-93 |
0.51 (0.34-0.77) |
0.68 (0.41-1.13) |
| >93 |
0.22 (0.12-0.39) |
0.39 (0.20-0.76) |
| CSP IgG3 |
<2 |
1 |
1 |
X2=1.41 (2), P=0.4932 N=401 |
| 2-99 |
0.45 (0.29-0.70) |
0.79 (0.47-1.34) |
| >99 |
0.59 (0.40-0.88) |
1.10 (0.68-1.79) |
| LR: Logistic Regression; CI: Confidence Interval; X2: Chi squared; P: p-value; N: Number of individuals tested |
